Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • 'Microlesions' in epilepsy discovered by novel technique

  • Imaging scan records brain activity during epileptic a

  • Master regulator gene, long tied to autism disorders, can stimulate other genes involved in early brain development

  • Little evidence brain games boost intelligence or prevent dementia

  • Limit imaging scans for headache? Neurosurgeons raise concerns

  • Existing drug, riluzole, may prevent foggy 'old age' brain, research shows

  • Using light to understand the brain

  • New non-invasive method can detect Alzheimer's disease early

  • Why some antidepressants may initially worsen symptoms

  • Of bugs and brains: Striking similarities in brain structures across invertebrates

  •